3193% Rally YTD: After 9:5 Bonus Issue, Small Cap Stock Sets Record Date For 1:2 Stock Split

Small cap stock Remedium Lifecare Ltd on Tuesday fixed September 1, 2023 as the record date for stock split in the ratio of 1:2. Remedium Lifecare shares witnessed sharp rally in last few years as it offered 3259% return in last 1-year only.

What Is Stock Split?: When a company announces stock split, it leads to increased number of shares of that company with the market cap remaining same. The current shares split with the underlying value remaining similar. When the number of shares rise, the price per share declines. The companies go for stock split to make the share more affordable for investors who may find it difficult to buy the shares of that company due to high prices.

Remedium Lifecare Sets Record Date For Stock Split: According to the BSE filing of Remedium Lifecare dated August 8, 2023, the Company has fixed Friday, September 01, 2023 as the Record Date for the purpose of ascertaining the names of the Shareholders who would be entitled to receive 2(Two) Equity Shares of the Face Value of Rs. 5/-each for every 1 (One) Equity Share of Face Value of Rs.10/- each held by them.

Remedium Lifecare Bonus Issue: Earlier, the company declared 9:5 bonus issue and fixed its record date as July 29, 2023. As per its BSE filing, "Remedium Lifecare Limited ("the Company") has fixed the Record date as Saturday, 29^TM July, 2023 in order to determine the number of shareholders entitled for Bonus Equity shares in the ratio of 9:5 (i.e., Nine Equity Shares of Rs. 10/- each fully paid up for every Five Equity Shares of Rs. 10/- each fully paid up held as on the record date decided for this purpose)."

Remedium Lifecare Stock Performance & Return: Last trading price of Remedium Lifecare share is Rs 1640.10 apiece with intraday gain of 0.38%. Its 52-week high price is Rs 1796.60 apiece and 52-week low price is Rs 48.61 apiece, respectively. It has a market capitalisation of Rs 1653.22 crore. In last 6-months, Remedium Lifecare shares surged 1661%, gained 3259% in last 1-year, soared 3430% in last 2-years, and witnessed maximum jump of 16,517% in last 3-years.

Remedium Lifecare Financial Performance: The company for the quarter ended March 31, 2023 announced its standalone total income at Rs 75.58 crore, down 57% as compared to its last quarter total income of Rs 176.50 crore. It announced its latest quarter net profit after tax at Rs -4.78 crore.

Remedium Lifecare About: It is a leading pharmaceutical company aligned across two business verticals viz. Products and Services. Its products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets, according to its official website.

Disclaimer: The stock just highlights the bonus issue, stock split and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for ay losses. Please consult a professional advisor.